Erasca, Inc.

At Erasca, their name is their mission: To erase cancer. They are a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Their company was co-founded by leading pioneers in precision oncology and RAS targeting to create novel therapies and combination regimens designed to…More comprehensively shut down the RAS/MAPK pathway for the treatment of cancer. They have assembled what they believe to be the deepest RAS/MAPK pathway-focused pipeline in the industry. They believe their team’s capabilities and experience, further guided by their scientific advisory board which includes the world’s leading experts in the RAS/MAPK pathway, uniquely position them to achieve their bold mission of erasing cancer.